metabolic disorder
Showing 1 - 18 of 18
Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Mediterranean diet supplement with 20 g / day of hemp
Completed
- Obesity
- +4 more
- Mediterranean diet supplement with 20 g / day of hemp protein.
-
Seville, SpainUniversity of Seville
Nov 8, 2023
Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Oral lipid emulsions)
Not yet recruiting
- Obesity
- +4 more
- Oral lipid emulsions
-
Seville, SpainUniversity of Seville
Sep 19, 2023
Inflammation, Metabolic Disorder, Hypertriglyceridemia Trial in Bozeman (Aronia juice, Placebo)
Completed
- Inflammation
- +2 more
- Aronia juice
- Placebo
-
Bozeman, MontanaNutrition Research Laboratory
Feb 15, 2022
Kidney Transplantation, Metabolic Disorder, Metformin Trial (SGLT2 inhibitor, Metformin, Placebo)
Not yet recruiting
- Kidney Transplantation
- +3 more
- SGLT2 inhibitor
- +2 more
- (no location specified)
Aug 13, 2021
Obesity, Disorder of Lipid Storage and Metabolism, Lipid Metabolism Disorders Trial in Orlando (Exercise)
Active, not recruiting
- Obesity
- +3 more
- Exercise
-
Orlando, FloridaTranslational Research Institute for Metabolism and Diabetes
Jul 13, 2021
Metabolic Disorder, End Stage Renal Disease, Rare Diseases Trial (Rheopheresis procedure, Sham-apheresis)
Not yet recruiting
- Metabolic Disorder
- +2 more
- Rheopheresis procedure
- Sham-apheresis
- (no location specified)
Dec 2, 2020
Hypertension, Metabolic Disorder Trial (continuous positive airway pressure)
Completed
- Hypertension
- Metabolic Disorder
- continuous positive airway pressure
- (no location specified)
Jul 14, 2020
Evaluation of Arginine in Periodontal and Cardiovascular Disease
Completed
- Metabolic Disorder
- Arginine; Hyperaminoaciduria
- Evaluation of arginine serum level
-
Messina, ItalyUniversity of Messina
Oct 3, 2019
Preventing and Treating Cardiotoxicity Induced by Anticancer
Recruiting
- Cardiovascular Complication
- +7 more
- Anti-Cancer Agents
-
Paris, France
- +2 more
Sep 24, 2019
Air Pollution and Cardiovascular Disease
Completed
- Metabolic Disorder
- (no location specified)
Jul 10, 2018
Metabolic Disorder Trial in Sydney (Product A: NP-0148, Glucose solution, Product B: NP-0149)
Completed
- Metabolic Disorder
- Product A: NP-0148
- +5 more
-
Sydney, New South Wales, AustraliaUniversity of Sydney
Sep 13, 2017
Lipid Metabolism, Inborn Errors, Hyperlipidemias, Metabolic Diseases Trial in Amsterdam (mipomersen, Placebo)
Completed
- Lipid Metabolism, Inborn Errors
- +13 more
- mipomersen
- Placebo
-
Amsterdam, Netherlands(unnamed)
Sep 9, 2016
Lipid Metabolism, Inborn Errors, Hypercholesterolemia, Autosomal Dominant, Hyperlipidemias Trial in United States (mipomersen
Completed
- Lipid Metabolism, Inborn Errors
- +13 more
- mipomersen sodium
-
Chicago, Illinois
- +4 more
Aug 1, 2016
Lipid Metabolism, Inborn Errors, Hypercholesterolemia, Autosomal Dominant, Hyperlipidemias Trial in Worldwide (Mipomersen
Completed
- Lipid Metabolism, Inborn Errors
- +13 more
- Mipomersen Sodium
-
Mission Viejo, California
- +32 more
Aug 1, 2016
Metabolic Diseases, Hyperlipidemias, Metabolic Disorder Trial in Amsterdam (mipomersen, )
Completed
- Metabolic Diseases
- +5 more
- mipomersen
- placebo
-
Amsterdam, Netherlands(unnamed)
Aug 1, 2016
Lipid Metabolism, Inborn Errors, Hypercholesterolemia, Autosomal Dominant, Hyperlipidemias Trial in Worldwide (mipomersen,
Completed
- Lipid Metabolism, Inborn Errors
- +13 more
- mipomersen
- Placebo
-
Charlotte, North Carolina
- +9 more
Aug 1, 2016
Diabetes, Type 1, Metabolic Disorder Trial in Spain (Control, Telecare system)
Completed
- Diabetes Mellitus, Type 1
- Metabolic Disorder
- Control
- Telecare system
-
Barakaldo, Spain
- +4 more
Jan 28, 2015
Metabolic Disorder Trial (Multidimensional lifestyle intervention)
Completed
- Metabolic Disorder
- Multidimensional lifestyle intervention
- (no location specified)
Nov 29, 2012